Analysts Set Revvity, Inc. (NYSE:RVTY) Target Price at $117.92

Shares of Revvity, Inc. (NYSE:RVTYGet Free Report) have earned an average rating of “Moderate Buy” from the fourteen brokerages that are presently covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $117.92.

A number of research firms have weighed in on RVTY. TD Cowen raised their price target on Revvity from $123.00 to $130.00 and gave the company a “buy” rating in a research report on Tuesday, April 30th. Jefferies Financial Group assumed coverage on Revvity in a research report on Monday. They set a “hold” rating and a $115.00 price target on the stock. Finally, Robert W. Baird lifted their price objective on Revvity from $126.00 to $127.00 and gave the stock an “outperform” rating in a report on Tuesday, April 30th.

Read Our Latest Analysis on RVTY

Revvity Price Performance

NYSE:RVTY opened at $111.02 on Tuesday. The firm has a market capitalization of $13.70 billion, a price-to-earnings ratio of 91.75, a P/E/G ratio of 2.82 and a beta of 1.08. Revvity has a 52-week low of $79.50 and a 52-week high of $131.96. The stock has a fifty day moving average of $105.79 and a 200 day moving average of $104.18. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.92 and a current ratio of 2.23.

Revvity (NYSE:RVTYGet Free Report) last released its quarterly earnings results on Monday, April 29th. The company reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.04. Revvity had a return on equity of 7.37% and a net margin of 5.49%. The business had revenue of $649.90 million for the quarter, compared to the consensus estimate of $646.83 million. During the same quarter last year, the business posted $1.01 earnings per share. The company’s revenue for the quarter was down 3.7% on a year-over-year basis. On average, research analysts expect that Revvity will post 4.65 EPS for the current fiscal year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 19th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $0.28 annualized dividend and a dividend yield of 0.25%. Revvity’s payout ratio is presently 23.14%.

Institutional Trading of Revvity

Several large investors have recently modified their holdings of RVTY. Vanguard Group Inc. bought a new stake in Revvity during the 3rd quarter valued at approximately $1,579,487,000. Capital Research Global Investors bought a new stake in Revvity during the 4th quarter valued at approximately $838,080,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Revvity during the 4th quarter valued at approximately $188,368,000. Norges Bank bought a new stake in Revvity during the 4th quarter valued at approximately $129,483,000. Finally, Northern Trust Corp bought a new stake in Revvity during the 4th quarter valued at approximately $127,401,000. 86.65% of the stock is owned by institutional investors.

Revvity Company Profile

(Get Free Report

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Further Reading

Analyst Recommendations for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.